{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:48:15Z","timestamp":1789465695501,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.reumae.2025.501816","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:56:12Z","timestamp":1746060972000},"page":"501816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of the anti-RO\/SSA antibody in patients with systemic lupus erythematosus"],"prefix":"10.1016","volume":"21","author":[{"given":"Paula P\u00e9rez","family":"Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura T\u00edo","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis Andr\u00e9u","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Carlos","family":"Salman-Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Carri\u00f3n-Barber\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501816_bib0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.reuma.2017.06.009","article-title":"Prevalencia de enfermedades reum\u00e1ticas en poblaci\u00f3n adulta en Espa\u00f1a (estudio EPISER 2016). Objetivos y metodolog\u00eda","volume":"15","author":"Seoane-Mato","year":"2019","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.reumae.2025.501816_bib0145","series-title":"Interpretaci\u00f3n de los autoanticuerpos en Enfermedades Reumatol\u00f3gicas","author":"Mendez-Rayo","year":"2018"},{"key":"10.1016\/j.reumae.2025.501816_bib0150","series-title":"Importancia Cl\u00ednica y Patog\u00e9nica de Anticuerpos anti Ro y anti La en Lupus Eritematoso Sist\u00e9mico","author":"Pacheco","year":"2004"},{"key":"10.1016\/j.reumae.2025.501816_bib0155","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/art.1780370916","article-title":"Specificity of autoantibodies for recombinant 60-kD and 52-kD ro autoantigens","volume":"37","author":"Williams Clair","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501816_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome","volume":"76","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501816_bib0165","article-title":"Clinical significance of different profiles of anti-Ro antibodies in connective tissue diseases","author":"Yang","year":"2023","journal-title":"U.S. National Library of Medicine"},{"key":"10.1016\/j.reumae.2025.501816_bib0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acr.20648","article-title":"Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort","volume":"64","author":"Urowitz","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.reumae.2025.501816_bib0175","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501816_bib0180","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501816_bib0185","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the systemic lupus international collaborating clinics\/American college of rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501816_bib0210","unstructured":"Cima. Ficha t\u00e9cnica Benlysta 120mg polvo para concentrado para soluci\u00f3n para perfusi\u00f3n [Internet]. Cima.aemps.es. 2016. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/11700001\/FT_11700001.html [cited 9.4.24]."},{"key":"10.1016\/j.reumae.2025.501816_bib0215","article-title":"Belimumab, a useful alternative therapy in systemic lupus erythematosus serositis","author":"Salman-Monte","year":"2021","journal-title":"U.S. National Library of Medicine"},{"key":"10.1016\/j.reumae.2025.501816_bib0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","article-title":"Systemic lupus erythematosus with Sj\u00f6gren syndrome compared to systemic lupus erythematosus alone","volume":"18","author":"Yao","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0270","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.090866","article-title":"Similarities and differences between primary and secondary Sj\u00f6gren's syndrome","author":"Hern\u00e1ndez-Molina","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.reuma.2010.06.001","article-title":"Manejo de las manifestaciones extraglandulares del s\u00edndrome de Sj\u00f6gren primario","volume":"6","author":"Rosas G\u00f3mez de Salazar","year":"2010","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.reumae.2025.501816_bib0230","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","article-title":"Sj\u00f6gren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sj\u00f6gren's syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501816_bib0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"Suppl. 126","key":"10.1016\/j.reumae.2025.501816_bib0240","first-page":"134","article-title":"Anti-Ro52 and\/or anti-Ro60 immune reactivity: autoantibody and disease associations","volume":"38","author":"Zampeli","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/03009742.2021.1887927","article-title":"Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients","volume":"50","author":"Lee","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2025.501816_bib0255","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s10067-021-05749-w","article-title":"Clinical features and risk factors of Raynaud's phenomenon in primary Sj\u00f6gren's syndrome","volume":"40","author":"Lin","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501816_bib0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2021.04.020","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases","volume":"91","author":"Decker","year":"2021","journal-title":"Eur J Intern Med (Leicester)"},{"key":"10.1016\/j.reumae.2025.501816_bib0265","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","article-title":"Diagnostic utility of separate anti-Ro60 and anti-Ro52\/TRIM21 antibody detection in autoimmune diseases","volume":"10","author":"Robbins","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.reumae.2025.501816_bib0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","article-title":"Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain","volume":"12","author":"Menor Almagro","year":"2016","journal-title":"Reumatol Cl\u00edn"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432500036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432500036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T22:58:08Z","timestamp":1758668288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357432500036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S217357432500036X"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501816","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the anti-RO\/SSA antibody in patients with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501816"}}